Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/26/01 → 11/30/06 |
Funding
- Bristol Myers Squibb Company: $13,458.00
AI424-043-040 An Open-Label Study of the Antiviral Efficacy and Safety of a Novel HIV & Prolease Inhibitor BMS-232632 Versus Lopinavir
- Greenberg, Richard (PI)
- Pomeroy, Claire (CoI)